nach oben

Antimicrobial Resistance & Infection Control

Erschienen in:

Open Access 01.12.2017 | Research

The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors

verfasst von: Ye-Mun Low, Polly Soo-Xi Yap, Kartini Abdul Jabar, Sasheela Ponnampalavanar, Rina Karunakaran, Rukumani Velayuthan, Chun-Wie Chong, Sazaly Abu Bakar, Mohd Yasim Md Yusof, Cindy Shuan-Ju Teh

Erschienen in: Antimicrobial Resistance & Infection Control | Ausgabe 1/2017

Abstract

Background

Carbapenem resistant Enterobacteriaceae is a growing concern worldwide including Malaysia. The emergence of this pathogen is worrying because carbapenem is one of the 'last-line' antibiotics. The main objective of this study was to determine the prevalence of genetic mechanisms and clinical risk factors of carbapenem resistant Klebsiella pneumoniae (K. pneumoniae) in Malaysia.

Methods

In this study, seventeen carbapenem resistant K. pneumoniae strains isolated from a tertiary teaching hospital in 2013 were studied. Minimal inhibitory concentration (MIC) of the bacterial strains was determined and genes associated with carbapenemases and extended-spectrum-beta-lactamases (ESBLs) were sequenced and compared with the closest representatives published in public domains. All strains were also sub-typed using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Statistical analyses were performed to determine the correlation between risk factors for acquiring carbapenem resistant K. pneumoniae and in-hospital mortality.

Results

The predominant carbapenemase was bla _OXA-48, detected in 12 strains (70.59%). Other carbapenemases detected in this study were bla _KPC-2, bla _IMP-8, bla _NMC-A and bla _NDM-1. Nine different pulsotypes were identified and nine strains which were affiliated with ST101, the predominant sequence type had similar PFGE patterns (similarity index of 85%). Based on univariate statistical analysis, resistance to imipenem and usage of mechanical ventilation showed a statistically significant effect separately to in-hospital mortality.

Conclusion

The diverse genetic mechanisms harbored by these carbapenem resistant K. pneumoniae facilitates its spread and complicates its detection. Thus, correlation between microbiological trends with host characteristics and clinical factors will provide a better insight of rational treatment strategies and pathogen control.

AST

Antimicrobial susceptibility testing

CLSI

Clinical and Laborartory Standards Institute

ESBL

Extended spectrum beta-lactamase

EUCAST

European Committee on Antimicrobial Susceptibility Testing

ICU

Intensive care unit

MHT

Modified Hodge test

MIC

Minimal inhibitory concentration

MLST

Multilocus sequence typing

PFGE

Pulsed-field gel electrophoresis

PTBD

Percutaneous transphetic biliary drainage

RND

Resistance-nodulation-cell division

SDD

Susceptible dose dependent

Sequence type

Background

Klebsiella pneumoniae (K. pneumoniae) is an important pathogen responsible for many healthcare associated infections. This Gram-negative bacterium affiliated with the Enterobacteriaceae family is the fourth and fifth most common cause of pneumonia and bacteremia respectively, among intensive care units (ICU), newborn units and in immunocompromised patients [1, 2]. In hospital environments, Klebsiella species survive and multiply in wet environmental sites and colonize the human bowel, bladder, upper respiratory tract and skin [3].

During the 1990s, extended-spectrum beta-lactamases (ESBLs) producing Klebsiella species that are able to hydrolyze broad and extended-spectrum cephalosporins, monobactams and penicillins were reported [4]. Thus, carbapenems, one of the 'last resort antibiotics' were often used to treat serious infections caused by ESBL carrying pathogens.

K. pneumoniae was first reported to harbor Klebsiella pneumoniae carbapenemase (KPC), one of the epidemiologically important carbapenemases first detected in North Carolina, USA in 1996 [5]. It was later identified in outbreaks in USA and was soon detected in many European countries and South America [6]. Initially, it was thought that carbapenemases were attributed to chromosomally encoded beta-lactamases and can only be transferred through clonal spread. However, plasmid encoded bla _IMP-1 and bla _KPC-1 reported in the 1990s [7] confirmed the presence of these resistance genes in mobile genetic elements which implicates potential for resistance transmission through horizontal gene transfer.

The first report of carbapenem resistant K. pneumoniae in Malaysia was an imipenem resistant strain isolated from blood culture of a 42-year old woman in 2004 [8]. To date, carbapenemases harbored by K. pneumoniae isolated in Malaysia identified using Pubmed search were NDM-1 [9, 10], OXA-232 [9] and IMP-4 [11].

In this study, we investigated the genotypic characteristics of carbapenem resistant K. pneumoniae isolated from patients in a tertiary teaching hospital in Malaysia. Their association with Tn4401 and the loss of porin as well as their subtypes were identified. Further risk factors associated with in-hospital mortality rate were also evaluated.

Methods

Bacterial isolates

A total of seventeen Klebsiella pneumoniae strains isolated within an eight-month period in 2013 since the first report of carbapenem resistant Enterobacteriaceae in this tertiary teaching hospital were revived from stock cultures. Antimicrobial susceptibility testing (AST) was conducted and carbapenemase production of the strains was detected by the Modified Hodge Test (MHT) (K. pneumoniae ATCC® BAA-1705 and K. pneumoniae ATCC® BAA-1706 as MHT positive and negative reference strain respectively). Clinical records of the patients from whom strains were isolated were retrieved from the hospital database and ethics approval (MEC:1059.15) was obtained from University of Malaya Medical Centre (UMMC) Ethics Committee prior to the start of this study.

Determination of minimal inhibitory concentration (MIC)

These seventeen strains which had been previously detected as resistant to imipenem and/or meropenem based on Clinical and Laboratory Standards Institute (CLSI) guidelines [12] by the hospital's diagnostic microbiology lab were subjected to E-test (bioMérieux, USA) using E. coli ATCC® 25922 as the quality control strain for susceptibility testing. The MIC values (μg/ml) for tigecycline, tetracycline, cefoxitin, cefotaxime, ceftazidime, ceftriaxone, cefepime, imipenem, meropenem, ertapenem, gentamicin, tobramycin, amikacin, aztreonam, ciprofloxacin, levofloxacin and colistin were determined. The results were interpreted using CLSI guidelines [12] while susceptibility to colistin and tigecycline were interpreted according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints [13]. In brief, imipenem and meropenem resistance were defined as MIC ≥4 μg/ml while ertapenem resistance was defined as MIC ≥2 μg/ml.

Pulsed-field gel electrophoresis (PFGE)

The clonal relatedness of these seventeen strains was determined using PFGE. Briefly, plugs containing whole genomic DNA of K. pneumoniae strains were digested with XbaI. The DNA fragments were separated in a PFGE CHEF-DR III system (Bio-Rad, UK). PFGE conditions of XbaI macrorestriction analysis were 6Vcm^-1 for 20 hours, with pulse times ranging from 5 s to 30s at a temperature of 14 °C and at an angle of 120°. The banding patterns were analyzed using BioNumerics software and similarity >85% upon dendrogram analysis was considered to represent the same PFGE pattern groups.

Multilocus sequence typing (MLST)

Seven housekeeping genes of K. pneumoniae namely, gapA, infB, mdh, pgi, phoE, rpoB and tonB were sequenced and analyzed using Institut Pasteur MLST and whole genome MLST database for K. pneumoniae, http://bigsdb.web.pasteur.fr/klebsiella/klebsiella.html. Each locus was assigned an allele number and the sequence type (ST) of each strain was determined based on the allelic profile generated using the allele numbers of the seven loci.

Detection of carbapenemases, AmpC beta-lactamases, extended-spectrum beta-lactamases (ESBL) and outer membrane porin genes

Carbapenemase genes such as KPC [14], OXA-48 [15], IMP, VIM [16], NDM [6], NMC, IMI, SIM, SPM [7], GIM [17], AmpC beta-lactamases (CMY, DHA, ACC, FOX) [18] as well as other ESBL associated genes such as TEM, SHV [18], OXA-1 [19], OXA-9 [15], CTXM-1, CTXM-2 [20] were amplified via PCR. The amplified products were sequenced and gene types were compared to the nearest gene homology using a BLAST search. The presence of porin associated genes namely ompK35, ompK36 and ompK37 [21] were also determined by PCR.

Determination of genetic elements of Tn4401

Genetic elements of Tn4401, a 10 kb Tn3 based transposon commonly found to harbor bla _KPC was determined as previously described [14, 22]. The unconserved region located between ISKpn7 and bla _KPC gene was also amplified to determine the isoforms of Tn4401.

Statistical analyses

Risk factors associated with in-hospital mortality were compared statistically depending on the level of measurement. Specifically nominal parameters (eg. mechanical ventilation, resistance to antibiotics, etc) were compared using chi-square or Fishers' exact test as appropriate while continuous variables (age and length of hospitalization) were analyzed using either student t test or Mann Whitney U test depending on data normality. P values less than 0.05 were deemed as statistically significant. Multiple logistic regression was not included in this study due to the small sample size. Continuous variables were summarized as mean ± standard deviation or median (inter quartile range) for both normal and non-normal distribution respectively.

Results

Overview of carbapenem resistant Klebsiella pneumoniae cases

The first case of carbapenem resistant K. pneumoniae in this study was detected from blood culture of a 57-year-old male patient in April 2013 in this 1,000 bed tertiary teaching hospital in Kuala Lumpur, Malaysia. Since then, no new cases were reported until another carbapenem resistant K. pneumoniae isolation from peritoneal drainage of a 67-year-old male patient in August 2013. In the following weeks, an average of one new carbapenem resistant case was detected every 2 weeks and as of 19 December 2013, a total of seventeen strains which were resistant to imipenem and/or meropenem were identified from blood (n = 4), urine (n = 4), swabs (stoma, perirectal, foot) (n = 3), drainage fluids (percutaneous transphetic biliary drainage (PTBD), peritoneal) (n = 2), tracheal secretion (n = 1), tracheal aspirate (n = 1), sputum (n = 1) and tissue (n = 1)). The time-line of events during in-patient admission period including the wards stayed and carbapenem resistant K. pneumoniae strains isolation from the sixteen patients from March 2013 to April 2014 was illustrated in Fig. 1. Four of the patients stayed in surgical wards, four in medical wards, two in orthopedic wards and six others moved from different wards. A total of four patients stayed in ICU during their admission period.

These strains were the first carbapenem resistant K. pneumoniae isolate from each patient with the exception of two strains which were isolated from a 60-year-old male patient. The first strain isolated from this patient was in October 2013 from tracheal aspirate. Subsequently, we did not identify carbapenem resistant K. pneumoniae from respiratory samples with the Vitek2 automated susceptibility testing system in 2013 while urine samples had no growth from October until November 2013. However, carbapenem resistant K. pneumoniae was detected in this patient's urine samples in December 2013.

This study was conducted in a multiracial community in Malaysia which comprises of three major races namely Malays, Chinese and Indians. There were nine male patients and seven female patients. The mean age of the patients was 66.13 years where the youngest patient was 48-years-old while the eldest was 85-years-old (Table 1). The average length of hospitalization prior to strain isolation was 65.18 days. Two carbapenem resistant K. pneumoniae strains (K/1309-38 and K/1311-26) were isolated from urine and blood respectively from two different patients within 48 hours of admission and one of the patients (K/1309-38) had came into contact with healthcare facilities in the past 30 days for endoscopic procedures. All patients in this study had co-morbidities such as diabetes mellitus, hypertension, chronic kidney disease and solid organ tumors. Diabetes mellitus and hypertension were the predominant non-communicable diseases identified in these patients.

Table 1

Clinical cases of patients from whom carbapenem resistant Klebsiella pneumoniae was isolated

Isolate	Gender/ Age (years)	Underlying diseases	Isolation site	Length of hospitalization prior to strain isolation (days)	Stay in ICU (days)	Undergone surgical procedure	Use of medical devices^a	Prior antibiotic exposure (90 days prior to strain isolation)	Empiric antibiotic	Targeted antibiotic	Colonization / Infection	In-hospital death
K/1310-23	M / 85	SOT	Blood	5	0	No	MV, Cath	XM, CI	TZP	CT	Infection	Yes
K/1311-36	M / 72	HPT	Drainage fluid	37	17	Yes	MV, Cath	CP, IP^b, PM, CLX, TX, CI, TZP, VA, MP^b	VA, MP	MP, CT	Infection	Yes
K/1308-12	M / 67	DM, HPT	Drainage fluid	21	0	Yes	MV, Cath	CP, MTZ	CI	IP, CT	Infection	No
K/1312-3	M / 60	DM, HPT	Urine	110	0	Yes	MV, Cath	P, TZP, IP^b	XM, IP	IP^d	Colonization	Yes
K/1310-33	F / 63	DM, HPT, CKD	Blood	24	0	Unknown	Cath	CFZ, TZ, VA, IP^b	CT	CT	Infection	No
K/1311-35	M / 71	DM, HPT	Sputum	108	5	Yes	Unknown	VA, CI, MP^b	TZ	Nil	Colonization	No
K/1312-17	F / 77	DM	Urine	16	0	Yes	Cath	CLX, AMS	CI	Nil	Colonization	No
AN9	F / 62	HPT	Urine	16	15	No	MV, Cath	CP, MTZ, AMS	TZP, IP^b	IP^d	Colonization	No
K/1309-5	F / 48	DM, HPT	Tissue	21	0	Yes	MV, Cath	AMS, AMC, TZP, IP^b	IP^b	Nil	Colonization	No
K/1310-24	F / 69	DM, HPT	Swab	155	0	Yes	MV, Cath	VA, MTZ, CT, IP^c, CI, XM, TZP	VA, TZP	VA, TZP	Colonization	No
KLEB-2013-105	F / 74	SOT	Swab	10	0	Yes	MV, Cath	OTC	AMS	Nil	Colonization	No
K/1309-18	F / 74	HPT	Tracheal secretion	10	11	Yes	MV, Cath	CP, MTZ	TZP	Nil^e	Infection	Yes
K/1309-39	M / 60	DM, HPT, CKD	Swab	3	0	Yes	Cath	AMS	AMS	IP, CT	Infection	No
K/1304-16	M / 57	DM, HPT	Blood	12	0	Yes	Cath	CI, TX	TZP	IP, CT	Infection	No
K/1309-38	M / 62	DM, SOT	Urine	0	0	Yes	MV, Cath	CI, CP, MTZ	TX	IP, CT	Infection	Yes
K/1311-26	F / 57	DM, HPT, SOT	Blood	0	0	Unknown	Unknown	AMS, CI	TX	Nil	Colonization	No
K/1310-35	M / 60	DM, HPT	Tracheal aspirate	67	0	Yes	MV, Cath	P, TZP	Nil	Nil	Colonization	Yes

M Male, F Female, SOT Solid organ tumor, DM Diabetes mellitus, HPT Hypertension, CKD Chronic kidney disease, ICU Intensive care unit, MV Mechanical ventilation, Cath catheter, Unknown patient's medical files could not be retrieved, XM Cefuroxime, CI Ciprofloxacin, TZP Piperacillin-tazobactam, CT Colistin, CP Cefoperazone, IP Imipenem, PM Cefepime, CLX Cloxacillin, TX Ceftriaxone, VA Vancomycin, MP Meropenem, MTZ Metronidazole, P Penicillin, CFZ Cefazolin, TZ Ceftazidime, AMS Ampicillin-sulbactam, AMC Amoxicillin-clavulanate, OTC Oxytetracycline

^amechanical ventilation and catheter; either urinary catheter, central venous catheter or drainage catheter, ^bcarbapenem exposure for more than 7 days, ^ccarbapenem exposure for 3 -7 days, ^dcarbapenem administered due to other infections, ^epatient passed away before targeted therapy was initiated

All 16 patients had been administered antibiotics over a period of 90 days prior to carbapenem resistant K. pneumoniae strain isolation. Cephalosporins and beta-lactam/beta-lactamase inhibitor combinations were the two most common classes of antibiotics being administered to them. These patients had been treated empirically with antibiotics such as beta-lactam/beta-lactamase inhibitors, carbapenems, cephalosporins, ciprofloxacin, vancomycin and colistin prior to carbapenem resistant K. pneumoniae identification (Table 1).

Eight patients (47.06%) in this study were infected with carbapenem resistant K. pneumoniae while others were considered to be colonized. Of the eight infected patients, one of them had changed their antimicrobial regimen to colistin while five others were given carbapenem and colistin combination. One patient (12.5%) died before changing therapy and another continued with colistin therapy.

Risk factors such as surgical procedures undergone, usage of mechanical ventilation and the usage of catheter were also taken into consideration. However, based on univariate analyses, only the usage of mechanical ventilation (P = 0.043) shows significant effect to in-hospital mortality rate (Table 2).

Table 2

Characteristics of carbapenem resistant Klebsiella pneumoniae associated with in-hospital mortality.

Characteristics	Survivors (n = 11)	Non-survivors (n = 6)	P
Age (years)	64.09 ± 2.57	68.83 ± 4.09	0.351^b
Ethnicity
Malay	2	2	0.317^c
Chinese	6	3	0.317^c
Indian	3	1	1.000^c
Gender
Male	4	5	0.111^c
Female	7	1	0.034^c
Underlying diseases
Hypertension	9 (82%)	4 (67%)	0.584
Diabetes mellitus	9 (82%)	3 (50%)	0.280
Solid organ tumor	2 (18%)	2 (33%)	0.584
Chronic kidney disease	2 (18%)	0 (0%)	0.515
Site of isolation
Blood	3 (27.3%)	1 (16.7%)	0.515
Swabs	3 (27.3%)	0 (0%)	0.515
Urine	2 (18.2%)	2 (33.3%)	0.58
Drainage fluids	1 (9.1%)	1 (16.7%)	1.000
Sputum	1 (9.1%)	0 (0%)	1.000
Tissue	1 (9.1%)	0 (0%)	1.000
Tracheal aspirate	0 (0%)	1 (16.7%)	0.353
Tracheal secretion	0 (0%)	1 (16.7%)	0.353
Length of hospitalization (days)	35.09 ± 14.88	38.17 ± 17.65	1.000^d
Stay in ICU	2 (18%)	2 (33%)	0.584
Undergone surgical procedure	8 (73%)	5 (83%)	1.000
Used ventilation devices	5 (45%)	6 (100%)	0.043
Used catheter	9 (82%)	6 (100%)	0.515
Antibiotic prescribed 90 days prior to strain isolation
Cephalosporins	6 (55%)	4 (67%)	1.000
Penicillins & beta-lactam/beta-lactamase inhibitors	6 (55%)	3 (50%)	1.000
Carbapenems	4 (36%)	2 (33%)	1.000
Colistin	1 (9%)	0	1.000
Others (ciprofloxacin, vancomycin, metronidazole & oxytetracycline)	8 (73%)	4 (67%)	1.000
Empiric treatment
Beta-lactam/beta-lactamase inhibitors	5 (46%)	2 (33%)	1.000
Cephalosporins	2 (18%)	2 (33%)	0.584
Carbapenems	2 (18%)	2 (33%)	0.584
Ciprofloxacin	2 (18%)	0	0.515
Vancomycin	1 (9%)	1 (17%)	1.000
Colistin	1 (9%)	0	1.000
Targeted therapy
Carbapenem + Colistin	3 (27%)	2 (33%)	1.000
Colistin	1 (9%)	1 (17%)	1.000
Carbapenem (Meropenem / Imipenem)	1 (9%)	1 (17%)	1.000
Vancomycin & Piperacillin-tazobactam	1 (9%)	0	1.000
Nil^a	5 (46%)	2 (33%)	1.000
Colonization / Infection
Colonization	7 (63%)	2 (33%)	0.162
Infection	4 (36%)	4 (67%)	0.162
Resistance to antibiotics (MIC)
Imipenem	10 (91%)	2 (33%)	0.04 ^c
Meropenem	9 (82%)	6 (100%)	0.515
Ertapenem	9 (82%)	5 (83%)	0.232^c
Carbapenemases
OXA-48	8 (73%)	4 (67%)	1.000
KPC-2	5 (45%)	3 (50%)	1.000
IMP-8	2 (18%)	0 (0%)	0.515
NMC-A	0 (0%)	2 (33%)	0.110
NDM-1	1 (9%)	0 (0%)	1.000
AmpC beta-lactamases
FOX-7	11 (100%)	6 (100%)	NA
ESBL
CTXM-2	11 (100%)	6 (100%)	NA
SHV	11 (100%)	6 (100%)	NA
OXA-1	7 (64%)	2 (33%)	0.335
CTXM-15	6 (55%)	4 (67%)	1.000
TEM	6 (55%)	3 (50%)	1.000
OXA-9	6 (55%)	1 (17%)	0.304^c

Values are expressed as n (%) except where otherwise noted.

^atargeted therapy was not administered as strain was colonizer or patient passed away before targeted therapy was initiated

P-values were obtained using Fishers' exact test unless noted otherwise. ^b P-values obtained using student t test, ^c P-values obtained using chi-square, ^d P-values obtained using Mann Whitney U test. The significant P values were highlighted in bold.

Determination of minimal inhibitory concentration (MIC)

The antibiotic profiles were tabulated in Table 3. Briefly, all strains were resistant to tetracycline (two strains were intermediate) but only one strain was resistant to tigecycline. Meanwhile, all strains were sensitive to colistin. Eight strains (47.06%) were resistant to all cephalosporins and all strains showed resistance to at least one carbapenem (MIC = 4 - >32 μg/ml) in this study. Resistance to imipenem was significantly associated with in-hospital mortality (P = 0.043) (Table 2). It was also noted that two strains (K/1311-35 and K/1304-16) were resistant to imipenem (MIC = 4 - 6 μg/ml) but were sensitive to meropenem and ertapenem while one strain (K/1312-3) was sensitive to imipenem but resistant to meropenem and ertapenem (MIC = 6 - 16 μg/ml). Furthermore, three strains (17.65%) were resistant to all aminoglycosides (MIC = 24 - >256 μg/ml for gentamicin and tobramycin; MIC = 64 - >256 μg/ml for amikacin) while thirteen strains (76.47%) were resistant to all fluoroquinolones (MIC = 8 - >32 μg/ml).

Table 3

MIC for the seventeen carbapenem resistant Klebsiella pneumoniae strains

Strains	Antibiotics (MIC range in μg/ml)
	^aTGC (≤1: S, >2: R)	TC (≤4: S, 8 = I, ≥16: R)	FX (≤8: S, 16 = I, ≥32: R)	CT (≤1: S, 2 = I, ≥4: R)	TZ (≤4: S, 8 = I, ≥16: R)	TX (≤1: S, 2 = I, ≥4: R)	PM (≤2: S, 4-8 = SDD, ≥16: R)	IP (≤1: S, 2 = I, ≥4: R)	MP (≤1: S, 2 = I, ≥4: R)	ETP (≤0.5: S, 1 = I, ≥2: R)	GM (≤4: S, 8 = I, ≥16: R)	TM (≤4: S, 8 = I, ≥16: R)	AK (≤16: S, 32 = I, ≥64: R)	AT (≤4: S, 8 = I, ≥16: R)	CI (≤1: S, 2 = I, ≥4: R)	LE (≤2: S, 4 = I, ≥8: R)	^aCT (≤2: S, >2: R)
K/1310-23	2	>256	>256	>256	>256	>256	>256	1.5	6	8	>256	>256	32	>256	>32	>32	1.5
K/1311-36	4	256	>256	256	>256	>256	>256	1.5	>32	6	0.094	0.19	0.5	>256	0.047	0.25	0.19
K/1308-12	1	>256	>256	>256	>256	>256	>256	>32	>32	>32	>256	48	24	>256	>32	>32	0.38
K/1312-3	2	>256	2	>256	>256	>256	24	1	6	16	0.38	1.5	256	48	>32	8	0.125
K/1310-33	0.75	>256	128	>256	48	>256	>256	>32	>32	>32	>256	>256	64	>256	>32	>32	0.06
K/1311-35	0.38	6	1.5	4	32	8	0.38	6	0.64	0.094	0.125	0.125	3	24	0.125	0.5	0.19
K/1312-17	0.75	>256	128	6	1	4	16	>32	>32	>32	>256	128	3	0.125	>32	>32	0.125
AN9	1.5	>256	48	4	0.38	2	1	>32	>32	>32	>256	8	3	0.19	>32	>32	0.125
K/1309-5	0.38	>256	>256	>256	128	>256	>256	2	>32	>32	>256	>256	24	>256	>32	>32	0.19
K/1310-24	0.5	>256	2	0.75	0.19	1.5	1.5	6	>32	6	0.19	0.19	1	0.047	0.5	0.5	0.125
KLEB 2013-105	0.19	>256	64	>256	128	>256	>256	>32	>32	>32	96	>256	24	>256	>32	>32	0.25
K/1309-18	0.75	>256	>256	6	0.5	3	2	>32	>32	>32	>256	6	4	0.25	>32	>32	0.25
K/1309-39	0.25	>256	>256	>256	>256	>256	64	12	>32	16	>256	>256	>256	>256	>32	>32	0.125
K/1304-16	1	>256	3	64	192	>256	24	4	0.064	0.125	>256	>256	>256	192	>32	>32	0.125
K/1309-38	0.19	>256	>256	>256	128	>256	>256	4	>32	>32	>256	24	12	>256	>32	>32	0.38
K/1311-26	1	>256	6	1	0.75	1	3	4	>32	24	>256	64	24	0.125	>32	>32	0.38
K/1310-35	0.25	6	3	0.75	0.094	1	0.125	3	>32	0.75	0.125	0.25	2	0.047	0.023	0.125	0.19

TGC Tigecycline, TC Tetracycline, FX Cefoxitin, CT Cefotaxime, TZ Ceftazidime, TX Ceftriaxone, PM Cefepime, IP Imipenem, MP Meropenem, ETP Ertapenem, GM Gentamicin, TM Tobramycin, AK Amikacin, AT Aztreonam, CI Ciprofloxacin, LE Levofloxacin, CT Colistin, S Sensitive, I Intermediate, R Resistant, SDD Susceptible-dose dependent

All MIC values were interpreted using CLSI, 2015 guidelines unless noted otherwise. ^aMIC values were interpreted based on EUCAST breakpoints, 2016

Molecular typing via PFGE & MLST

Based on the PFGE patterns obtained, the seventeen strains formed nine different pulsotypes while MLST analysis showed eight STs (Fig. 2). Nine strains affiliated with the predominant sequence type, ST101 demonstrated similar PFGE patterns (Dice index >85% homology) suggesting close intra ST-type genomic similarity. Five of the ST101 strains were isolated within a week apart from one another in August until September 2013 from patients who had stayed in surgical wards. Two weeks later, this sequence type was isolated from one patient in the medical ward and in the following months from two patients in medical wards and one patient from the orthopedic ward. It was also noted that three other sequence types, ST789, ST11 and ST495 were isolated from patients who had stayed in surgical wards two months after the first ST101 isolation and one of the patients had stayed in the surgical ward in August 2013. All ST101 strains in this study were highly resistant to meropenem (MIC >32 μg/ml) and ertapenem (MIC = 24 - >32 μg/ml). High MIC was also observed for imipenem (MIC >32 μg/ml) with the exception of three strains which had lower MICs ranging from 2 μg/ml (intermediate) to 4 μg/ml (resistant).

Similarly, two strains (K/1304-16 and K/1309-39) (Dice index = 84.2% homology) from the same sub-cluster were categorized into the same sequence type, ST147. However, two other strains, K/1310-35 and K/1312-3 which were isolated two months apart from a 60-year-old male patient exhibited distinct PFGE pattern and sequence type (ST397 and ST13 respectively); indicating low relatedness.

Detection of carbapenemases, AmpC beta lactamases, extended spectrum beta lactamases (ESBL) and porin protein genes

AmpC (bla _FOX-7) and ESBLs (bla _SHV, bla _TEM, bla _CTXM-2 bla _CTXM-15, bla _OXA-1, bla _OXA-9) were present in all 17 strains while carbapenemases (bla _KPC-2, bla _OXA-48, bla _IMP-8, bla _NDM-1, bla _NMC-A,) were detected in only 16 strains where bla _OXA-48 was the dominant carbapenemase (Table 4). All strains also exhibited the presence of three outer membrane porins (ompK35, ompK36, ompK37) with the exception of K/1310-24 where ompK36 was absent. This strain, K/1310-24 also showed the highest resistance towards imipenem (MIC = 6 μg/ml), meropenem (MIC = >32 μg/ml) and ertapenem (MIC = 6 μg/ml) among the group of six strains made up of sequence type other than ST101 and ST147.

Table 4

PCR results of gene specific primers depicting Carbapenemase, AmpC, ESBL, porin protein and Tn4401-like elements in carbapenem resistant Klebsiella pneumoniae strains

Strain	Sequence Type (ST)	Carbapenemase	AmpC	ESBL	Porin protein	Genetic elements surrounding Tn4401
Strain	Sequence Type (ST)	Carbapenemase	AmpC	ESBL	Porin protein	IRL	tnpA	ISKpn7	ISKpn6	Variable region	IRR
K/1310-23	11	-	FOX-7	SHV-11, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1311-36	495	KPC-2, NMC-A	FOX-7	TEM-135, SHV-12, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	+	-	+	-	+	+
K/1308-12	101	OXA-48	FOX-7	TEM-1, SHV-28, OXA-1, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1312-3	13	OXA-48, KPC-2, NMC-A	FOX-7	TEM-135, SHV-148, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	+	-	+	+
K/1310-33	101	OXA-48, KPC-2	FOX-7	TEM-1, SHV-28, OXA-1, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	+	+	+	-
K/1311-35	1245	KPC-2	FOX-7	SHV-12, CTXM-2	OmpK35, OmpK36, OmpK37	-	+	-	-	-	+
K/1312-17	101	OXA-48, KPC-2	FOX-7	SHV-28, OXA-1, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	+	-	-
AN9	101	OXA-48	FOX-7	SHV-28, OXA-1, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1309-5	101	OXA-48, KPC-2	FOX-7	TEM-1, SHV-28, OXA-1, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	+	+	+	-
K/1310-24	789	OXA-48, KPC-2	FOX-7	SHV-121, CTXM-2	OmpK35, OmpK37	-	-	+	-	+	+
KLEB 2013-105	101	OXA-48	FOX-7	TEM-1, SHV-28, OXA-1, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1309-18	101	OXA-48	FOX-7	SHV-28, OXA-1, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1309-39	147	IMP-8, NDM-1	FOX-7	TEM-1, SHV-11, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1309-38	101	OXA-48, KPC-2	FOX-7	TEM-1, SHV-28, OXA-1, OXA-9, CTXM-15, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	+	+	+	-
K/1311-26	101	OXA-48	FOX-7	SHV-28, OXA-1, CTXM-2	OmpK35, OmpK36, OmpK37	-	-	-	-	-	-
K/1310-35	397	OXA-48	FOX-7	SHV-1, CTXM-2	OmpK35, OmpK36, OmpK37	+	-	-	-	-	+

IRL inverted repeat left, tnpA transposase, ISKpn7 insertion sequence 7, ISKpn6 insertion sequence 6, IRR inverted repeat right

Characterization results for Tn4401

Primer pairs specific for different genetic elements on Tn4401 were used to deduce the structure of it. A schematic representation of a typical Tn4401 structure is shown in Fig. 3a. All strains harboring bla _KPC-2 showed the presence of Tn4401 elements which indicated that bla _KPC-2 gene was carried within Tn4401 transposon (Table 4).

Isoforms of Tn4401 were determined based on the fragment size of primer pair hybridizing ISKpn7 and bla _KPC; upstream of bla _KPC [22]. All six strains which showed positive amplification were of the same DNA fragment size (703 bp) and they belonged to isoform b where no deletion in the variable region is observed. Among these six strains, one was sensitive, two were intermediate while three exhibited resistance to imipenem (MIC = 4 - >32 μg/ml) but all strains were resistant to meropenem and ertapenem (MIC = 6 - >32 μg/ml). Both flanking sequences of Tn4401, inverted repeat left (IRL) and inverted repeat right (IRR) were present in three out of 17 strains (17.65%) while three others (17.65%) showed only one flanking sequence. Complete Tn4401 was not detected in this study as some elements were absent in all strains. Examples of truncated Tn4401 detected in this study were shown in Fig. 3b.

Discussion

Among the seventeen carbapenem resistant K. pneumoniae strains investigated, two of them (K/1310-35 and K/1312-3) showed distinct pulsotypes, sequence types and resistotypes, indicating non-clonal relationship despite being isolated from the same patient. During an outbreak investigation of ESBL producing K. pnemoniae in a neonatal intensive care unit in Germany, Haller and co-workers [23] found two isolates from the same patient taken 138 days apart to be affiliated with separate clusters on phylogenetic tree. This could indicate the presence of diverse pathogen populations within individuals which complicates treatment. These two strains isolated in this study were colonizers (strains isolated from tracheal aspirate and urine) and this patient died after 229 days of hospitalization. Dautzenberg and co-workers [24] have reported that patients colonized with carbapenem resistant Enterobacteriaceae have higher mortality rates as compared to non-colonized patients due to long hospital stay.

The administration of multiple antibiotics has been reported as a risk factor for carbapenem resistance acquisition [25] and all sixteen patients in this study were given at least one antibiotic in the past 90 days prior to carbapenem resistant K. pneumoniae isolation. Five patients had been administered with carbapenems for more than seven days and another for three days while the ten other patients were exposed to other beta-lactams (penicillins, beta-lactam/beta-lactamase inhibitors and cephalosporins), ciprofloxacin, vancomycin, metronidazole, oxytetracycline and colistin. This is agreeable with findings as shown by Patel and co-workers [26] that carbapenem resistance is not attributed only to previous exposure to carbapenem but also exposure to other antibiotics.

One strain, K/1310-23 harbored only AmpC (bla _FOX-7) and ESBLs (bla _SHV-11, bla _CTXM-15 and bla _CTXM-2) without the presence of carbapenemases or loss of porin but it was resistant to meropenem (MIC = 6 μg/ml) and ertapenem (MIC = 8 μg/ml). This may be due to reduced porin expression [27] in the strain or this strain may have harbored rare carbapenemases or variants that were not tested for in this study. Only strain, K/1310-24 was associated with loss of porin; ompK36 and it also harbored carbapenemases (bla _OXA-48 and bla _KPC-2)._. This strain also exhibited the highest resistance towards carbapenems in the group of strains other than ST101 and ST147 which supports the findings that loss of porin together with the presence of bla _KPC-2 is associated with elevated carbapenem MIC [28].

It was also observed that three strains exhibited varying susceptibility patterns to carbapenems tested in this study. K/1311-35 and K/1304-16 were resistant to imipenem but sensitive to meropenem and ertapenem while K/1312-3 was sensitive to imipenem but resistant to meropenem and ertapenem. This discrepany in resistance pattern often poses a challenge in carbapenem resistant detection especially if either imipenem or meropenem is used as a representative carbapenem in the screening system [29, 30]. Imipenem resistant, meropenem sensitive Pseudomonas aeruginosa and imipenem sensitive, meropenem resistant K. pneumoniae strains have been previously reported [30, 31]. This difference in susceptibility patterns can be attributed to the variation in outer membrane porin structure and the efflux pumps expression. The eight amino acid sequence deletion on loop L7 of OprD, a carbapenem-specific porin in P. aeruginosa sufficiently opens the porin channel, allowing optimal penetration of meropenem and increases its activity without affecting the susceptibility of smaller carbapenem molecules such as imipenem [32]. The overexpression of resistance-nodulation-cell division (RND) efflux pump in P. aeruginosa has also been reported to cause varying carbapenem MIC levels [33]. Thus, we postulate that there may be similar porin structure and efflux pump variations in K. pneumoniae that contribute to this discrepancy in carbapenem resistance.

Overall, PFGE and MLST produced comparable clustering results. The predominant sequence type, ST101 (n = 9) shared the same pulsotype. This characteristic had been reported by Kitchel and co-workers [34] where K. pneumoniae strains with ≥ 80% similarity in PFGE patterns strongly agreed with their MLST results. It was observed that ST101 spread occurred in the surgical ward in August 2013 as five of ST101 strains were isolated from five different patients who had stayed in surgical wards during this one month period. However, ST101 was also isolated from three other patients from medical wards and one patient from orthopedic ward in the following months. We postulate that more complicated transmission routes such as asymptomatic patients who were never detected, via health care personnel or medical devices [35] may have contributed to the spread of ST101 to patients from other wards. ST789, ST11 and ST495 were also isolated from three separate patients in surgical wards in October and November 2013 and one of the patients had came into contact with the ST101 harboring patients as they shared the same ward in August and was colonized. Despite being phylogenetically unrelated to ST101, these three strains harbor similar ESBL and carbapenemase genes indicating horizontal gene transfer may occur since these genes are often found on transposons and plasmids [36, 37].

Our finding of ST101 as a predominant strain is similar to the report of ST101 as a predominant K. pneumoniae clone in an acute general hospital in Italy [38]. ST101 was reported to be responsible for bla _OXA-48 outbreaks in Spain and Tunisia [36] and harboring bla _KPC-2 in Italy [38] which was comparable to our results where ST101 isolated were bla _OXA-48 with four co-producing bla _KPC-2.

Bla _OXA-48, which was first reported in Turkey [39] was also known to exhibit susceptibility towards extended-spectrum cephalosporins and carbapenems [40] which complicates the detection via routine clinical microbiology laboratory tests. Similarly, K/1310-35 (sensitive to all cephalosporins), K/1310-24 (intermediate to ceftriaxone while being sensitive to all other cephalosporins) and K/1311-26 (susceptible dose dependent (SDD) to cefepime while being sensitive to all other cephalosporins) harbored bla _OXA-48. Interestingly, these three strains also harbored bla _SHV and bla _CTXM which was known to hydrolyze cefotaxime and ceftazidime [41] but all three strains were sensitive to both antibiotics in this study.

Bla _KPC is endemic in northeastern regions in USA, Greece and Israel but cross regional spreading into United Kingdom, Brazil, Sweden, India and China had been reported recently [42]. This gene is often detected on mobile genetic elements such as plasmids and transposons which facilitates its rapid dissemination worldwide [37]. Bla _KPC-2 is generally associated with Tn4401 isoforms [43] and in this study, Tn4401b (no deletion in the variable region) was associated with six bla _KPC-2 harboring strains. This isoform had been reported to exhibit lower resistance to carbapenems as compared to other isoforms [28]. However, such conclusions cannot be made in this study as only one isoform type was detected in this study. To the best of our knowledge, this report presented the first identification of K. pneumoniae harboring bla _OXA-48 and bla _KPC-2 in Malaysia.

Two strains, K/1304-16 and K/1309-39 demonstrated slight differences in PFGE banding patterns (Dice homology = 84.2%) despite having the same sequence type, ST147. PFGE is able to detect chromosomal rearrangements [44] which may contribute to differences in their antibiotic and genotypic profiles. K/1309-39 was resistant to imipenem, meropenem and ertapenem (MIC = 12 - >32 μg/ml) while K/1304-16 demonstrated low resistance to imipenem, (MIC = 4 μg/ml) and was sensitive to both meropenem and ertapenem. Furthermore, bla _TEM carried by both strains was of different gene types. TEM-1 was present in K/1309-39 while TEM-135 was detected in K/1304-16. These two strains can also be distinguished further based on the presence of bla _NDM-1 in K/1309-39 and the presence of inverted repeats (IR) of Tn4401 in K/1304-16.

A majority of NDM cases reported worldwide were related to travel or hospitalization in the Indian subcontinent such as India and Pakistan [45] and ST147 has been shown to be associated with bla _NDM-1 in India [46]. However, in our study, the bla _NDM-1 positive patient had no record of prior travel outside Malaysia. The presence of bla _NDM without any association with international travel has also been reported by Rimrang and co-workers [47] which indicated that the NDM gene was acquired locally.

This study is limited by its small sample size as this study only includes the carbapenem resistant K. pneumoniae strains which were isolated during an eight months' period since the first carbapenem resistant K. pneumoniae isolation in this hospital. Thus, the findings cannot be generalized to a broader population based on this study alone as it may include potential biases. The significance of mortality rates with imipenem resistance as compared to meropenem and ertapenem resistance cannot be firmly drawn since all the studied strains were imipenem and / or meropenem resistant strains. The increased use of imipenem may have contributed to increased imipenem resistance [48] since five patients were administered with imipenem while only two patients were given meropenem. However, our findings that mechanical ventilation is associated with mortality can be justified as it was also reported in other studies [25, 49].

Conclusions

The emergence of carbapenem resistant K pneumoniae harboring various carbapenemases coupled with the presence of transposon and the loss of porin may contribute to the increasing cases being detected. Thus, microbiological, molecular and clinical data of these strains are important to provide information for a better understanding and to facilitate carbapenem resistance control.

Acknowledgments

Not applicable

Funding

This work was supported by Fundamental Research Grant Scheme (FRGS) from the Ministry of Education, Malaysia (grant number: FP023-2014A), University of Malaya Research Grant (UMRG) from University of Malaya (grant number: RP026B-14HTM) and International Society for Infectious Diseases (ISID) research grant (grant number: IF016-2015).

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors’ contributions

CSJT and MYMY designed the study. YML and PSXY carried out the experiments and collected the data. CWC performed the statistical analysis. KAJ, SP, RK and RV interpreted the clinical data. YML, KAJ, RK, CWC, SAB and CSJT wrote and revised the manuscript. All authors' read and approved the final version of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Not applicable

Ethics approval (MEC:1059.15) was obtained prior to the start of this study.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Bratu S, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165:1430–5. http://dx.doi.org/10.1001/archinte.165.12.1430.CrossRefPubMed

Oteo J, et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J Antimicrob Chemother. 2009;64:524–8. http://dx.doi.org/10.1093/jac/dkp211.CrossRefPubMed

Macrae MB, et al. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J Hosp Infect. 2001;49:183–92. http://dx.doi.org/10.1053/jhin.2001.1066.CrossRefPubMed

Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. 2006;119:S20–28. http://dx.doi.org/10.1016/j.amjmed.2006.03.013.CrossRefPubMed

Yigit H, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151–61. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001.CrossRefPubMedPubMedCentral

Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791–8. http://dx.doi.org/10.3201/eid1710.110655.CrossRefPubMedPubMedCentral

Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440–58. http://dx.doi.org/10.1128/CMR.00001-07.CrossRefPubMedPubMedCentral

Palasubramaniam S, Karunakaran R, Gan GG, Muniandy S, Parasakthi N. Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction. Int J Infect Dis. 2007;11:472–4. http://dx.doi.org/10.1016/j.ijid.2007.01.005.CrossRefPubMed

Al-Marzooq F, Ngeow YF, Tay ST. Emergence of Klebsiella pneumoniae producing dual carbapenemases (NDM-1 and OXA-232) and 16S rRNA methylase (armA) isolated from a Malaysian patient returning from India. Int J Antimicrob Agents. 2015;45:445–6. http://dx.doi.org/10.1016/j.ijantimicag.2014.12.013.CrossRefPubMed

10.

Ahmad N, et al. Characterization of the first isolate of Klebsiella pneumoniae carrying New Delhi metallo-beta-lactamase and other extended spectrum beta-lactamase genes from Malaysia. J Med Microbiol. 2013;62:804–6. http://dx.doi.org/10.1099/Jmm.0.050781-0.CrossRefPubMed

11.

Hamzan NI, Chan YY, Abdul Rahman R, Hasan H, Abdul Rahman Z. Detection of bla _IMP4 and bla _NDM1 harboring Klebsiella pneumoniae isolates in a university hospital in Malaysia. Emerg Health Threats J. 2015;8:26011. http://dx.doi.org/10.3402/ehtj.v8.26011.PubMed

12.

Clinical and Laboratory Standards Institute (CLSI). M100-S25: Performance Standards for antimicrobial susceptibility testing. Twenty-fifth international supplement. 2015;35:45–50.

13.

The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. 2016. Version 6.0, 2016. http://www.eucast.org/clinical_breakpoints/

14.

Naas T, et al. Genetic structures at the origin of acquisition of the beta-lactamase bla _KPC gene. Antimicrob Agents Chemother. 2008;52:1257–63. http://dx.doi.org/10.1128/AAC.01451-07.CrossRefPubMedPubMedCentral

15.

Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15–22. http://dx.doi.org/10.1128/AAC.48.1.15-22.2004.

16.

Yan JJ, et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother. 2001;45:2224–8. http://dx.doi.org/10.1128/AAC.45.8.2224-2228.2001.CrossRefPubMedPubMedCentral

17.

Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh T. Molecular characterization of a beta-lactamase gene, bla _GIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob Agents Chemother. 2004;48:4654–61. http://dx.doi.org/10.1128/AAC.48.12.4654-4661.2004.CrossRefPubMedPubMedCentral

18.

Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:490–5. http://dx.doi.org/10.1093/jac/dkp498.CrossRefPubMed

19.

Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli. Canada Emerg Infect Dis. 2011;17:103–6. http://dx.doi.org/10.3201/eid1701.101358.CrossRefPubMed

20.

Eckert C, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris. France Antimicrob Agents Chemother. 2004;48:1249–55. http://dx.doi.org/10.1128/AAC.48.4.1249-1255.2004.

21.

Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla _ACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob Agents Chemother. 2006;50:3396–406. http://dx.doi.org/10.1128/AAC.00285-06.CrossRefPubMedPubMedCentral

22.

Cuzon G, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase bla _KPC-2 gene. Emerg Infect Dis. 2010;16:1349–56. http://dx.doi.org/10.3201/eid1609.091389.CrossRefPubMedPubMedCentral

23.

Haller S, et al. What caused the outbreak of ESBL-producing Klebsiella pneumoniae in a neonatal intensive care unit, Germany 2009 to 2012? Reconstructing transmission with epidemiological analysis and whole-genome sequencing. BMJ Open. 2015;5:e007397. http://dx.doi.org/10.1136/bmjopen-2014-007397.CrossRefPubMedPubMedCentral

24.

Dautzenberg MJD, et al. The Association Between Colonization With Carbapenemase-Producing Enterobacteriaceae and Overall ICU Mortality: An Observational Cohort Study. Crit Care Med. 2015;43:1170–7. http://dx.doi.org/10.1097/Ccm.0000000000001028.CrossRefPubMedPubMedCentral

25.

Saidel-Odes L, Borer A. Limiting and controlling carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist. 2013;7:9–14. http://dx.doi.org/10.2147/IDR.S44358.PubMedPubMedCentral

26.

Patel N, et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother. 2011;66:1600–8. http://dx.doi.org/10.1093/jac/dkr156.CrossRefPubMed

27.

Crowley B, Benedi VJ, Domenech-Sanchez A. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother. 2002;46:3679–82. http://dx.doi.org/10.1128/Aac.46.11.3679-3682.2002.CrossRefPubMedPubMedCentral

28.

Kitchel B, et al. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2010;54:4201–7. http://dx.doi.org/10.1128/AAC.00008-10.CrossRefPubMedPubMedCentral

29.

Harino T, et al. Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems. J Clin Microbiol. 2013;51(8):2735–8. http://dx.doi.org/10.1128/JCM.02649-12.CrossRefPubMedPubMedCentral

30.

Shigemoto N, et al. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis. 2012;72(1):109–12. http://dx.doi.org/10.1016/j.diagmicrobio.2011.09.019.CrossRefPubMed

31.

Pai H, et al. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2001;45(2):480–4. http://dx.doi.org/10.1128/AAC.45.2.480-484.2001.CrossRefPubMedPubMedCentral

32.

Epp SF, et al. C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother. 2001;45(6):1780–7. http://dx.doi.org/10.1128/AAC.45.6.1780-1787.2001.CrossRefPubMedPubMedCentral

33.

Kao CY, et al. Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan. BMC Microbiol. 2016;16(1):107. http://dx.doi.org/10.1186/s12866-016-0719-2.CrossRefPubMedPubMedCentral

34.

Kitchel B, et al. Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258. Antimicrob Agents Chemother. 2009;53:3365–70. http://dx.doi.org/10.1128/Aac.00126-09.CrossRefPubMedPubMedCentral

35.

Snitkin E, et al. Tracking a hospital outbreak of carbapenem-resistant klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):14ra116. http://dx.doi.org/10.1126/scitranslmed.3004129.CrossRef

36.

Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill. 2013:18. http://dx.doi.org/10.2807/1560-7917.ES2013.18.31.20549.

37.

Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36. http://dx.doi.org/10.1016/S1473-3099(09)70054-4.CrossRefPubMed

38.

Mammina C, et al. Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy. Int J Antimicrob Agents. 2012;39:543–5. http://dx.doi.org/10.1016/j.ijantimicag.2012.02.012.CrossRefPubMed

39.

Pfeifer Y, et al. Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother. 2012;56:2125–8. http://dx.doi.org/10.1128/AAC.05315-11.CrossRefPubMedPubMedCentral

40.

Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67:1597–606. http://dx.doi.org/10.1093/jac/dks121

41.

Bradford PA. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933–51. http://dx.doi.org/10.1128/Cmr.14.4.933-951.2001.CrossRefPubMedPubMedCentral

42.

Arnold RS, et al. Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J. 2011;104:40–5. http://dx.doi.org/10.1097/SMJ.0b013e3181fd7d5a.CrossRefPubMedPubMedCentral

43.

Gootz TD, et al. Genetic organization of transposase regions surrounding bla_KPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital. Antimicrob Agents Chemother. 2009;53:1998–2004. http://dx.doi.org/10.1128/AAC.01355-08.CrossRefPubMedPubMedCentral

44.

Vimont S, Mnif B, Fevre C, Brisse S. Comparison of PFGE and multilocus sequence typing for analysis of Klebsiella pneumoniae isolates. J Med Microbiol. 2008;57:1308–10. http://dx.doi.org/10.1099/jmm.0.2008/003798-0.CrossRefPubMed

45.

Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol. 2013;62:499–513. http://dx.doi.org/10.1099/jmm.0.052555-0.CrossRefPubMed

46.

Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JDD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57:130–6. http://dx.doi.org/10.1128/AAC.01686-12.CrossRefPubMedPubMedCentral

47.

Rimrang B, et al. Emergence of NDM-1-and IMP-14a-producing Enterobacteriaceae in Thailand. J Antimicrob Chemother. 2012;67:2626–30. http://dx.doi.org/10.1093/jac/dks267.CrossRefPubMed

48.

McLaughlin M, et al. Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother. 2013;57(10):5131–3. http://dx.doi.org/10.1128/AAC.00607-13.CrossRefPubMedPubMedCentral

49.

Schwaber MJ, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52:1028–33. http://dx.doi.org/10.1128/AAC.01020-07.CrossRefPubMed

Titel: The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors
verfasst von: Ye-Mun Low
Polly Soo-Xi Yap
Kartini Abdul Jabar
Sasheela Ponnampalavanar
Rina Karunakaran
Rukumani Velayuthan
Chun-Wie Chong
Sazaly Abu Bakar
Mohd Yasim Md Yusof
Cindy Shuan-Ju Teh
Publikationsdatum: 01.12.2017
Verlag: BioMed Central
Erschienen in: Antimicrobial Resistance & Infection Control / Ausgabe 1/2017
Elektronische ISSN: 2047-2994
DOI: https://doi.org/10.1186/s13756-016-0164-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors

Abstract

Background

Methods

Results

Conclusion

Background

Methods

Bacterial isolates

Determination of minimal inhibitory concentration (MIC)

Pulsed-field gel electrophoresis (PFGE)

Multilocus sequence typing (MLST)

Detection of carbapenemases, AmpC beta-lactamases, extended-spectrum beta-lactamases (ESBL) and outer membrane porin genes

Determination of genetic elements of Tn4401

Statistical analyses

Results

Overview of carbapenem resistant Klebsiella pneumoniae cases

Determination of minimal inhibitory concentration (MIC)

Molecular typing via PFGE & MLST

Detection of carbapenemases, AmpC beta lactamases, extended spectrum beta lactamases (ESBL) and porin protein genes

Characterization results for Tn4401

Discussion

Conclusions

Acknowledgments

Funding

Availability of data and materials

Authors’ contributions

Competing interests

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Background

Methods

Bacterial isolates

Determination of minimal inhibitory concentration (MIC)

Pulsed-field gel electrophoresis (PFGE)

Multilocus sequence typing (MLST)

Detection of carbapenemases, AmpC beta-lactamases, extended-spectrum beta-lactamases (ESBL) and outer membrane porin genes

Determination of genetic elements of Tn4401

Statistical analyses

Results

Overview of carbapenem resistant Klebsiella pneumoniae cases

Determination of minimal inhibitory concentration (MIC)

Molecular typing via PFGE & MLST

Detection of carbapenemases, AmpC beta lactamases, extended spectrum beta lactamases (ESBL) and porin protein genes

Characterization results for Tn4401

Discussion

Conclusions

Acknowledgments

Funding

Availability of data and materials

Authors’ contributions

Competing interests

Consent for publication

Ethics approval and consent to participate

Weitere Artikel der Ausgabe 1/2017

Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties

High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting

Antimicrobial susceptibility of Brucella melitensis in Kazakhstan

Extended spectrum and metalo beta-lactamase producing airborne Pseudomonas aeruginosa and Acinetobacter baumanii in restricted settings of a referral hospital: a neglected condition

Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study

Why language matters: a tour through hand hygiene literature

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin